Clinical trials: Progesterone Induced Blocking Factor in Endometrial Cancer
Progesterone Induced Blocking Factor in Endometrial Cancer
Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.
Immune system suppression effect of Progesterone Induced Blocking Factor(PIBF), it could be questionable whether tumor cells express PIBF for escape of immune system.
- Trial name
- NCT02852954
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Kayseri Education and Research Hospital